Overview

Daily Low-level Red Light and 0.01% Low-dose Atropine for Myopia Prevention

Status:
COMPLETED
Trial end date:
2023-09-15
Target enrollment:
Participant gender:
Summary
To compare the preventive effects of daily low-level red-light and 0.01% low-dose atropine eye drops on myopia.
Phase:
NA
Details
Lead Sponsor:
Beijing Tongren Hospital
Treatments:
Atropine